focus -WSS

focus

author：comprehensive 2025-09-02 08:25:18 - browse：5

Sammy Kimball for STAT

Can Novavax finally get it right? What’s a “triple-G” drug? And is Novo Nordisk losing ground?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain how the era of Wegovy could be short-lived in light of powerful new weight-loss medicines from Eli Lilly. Then, John Jacobs, the new CEO of Novavax, stops by to explain his plan to right the ship at a company that has struggled to make the most of its potent Covid-19 vaccine.

For more on what we cover, here’s the news on Lilly; here’s more on Novavax; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： A biotech analyst on neuroscience, placebo effect, not over

focus

WSS

Hospital chaplains balance Covid safety with patients’ spiritual needs

American taxpayers paid $1.8 trillion in health care costs in 2022

Physician assistants need a new name. Here's what it should be

In same hospitals, Black patients receive fewer opioids than white patients

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

FDA early review: GLP

Wikipedia

focus

knowledge

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Stories you might have missed in 2023: health, science, medicine

United colonoscopy coverage change 'may cost lives,' doctors say

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Drastic changes should bring profitability, startup health insurers say

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Anavex keeps shifting the goalposts in its clinical trials

Heart attack and stroke risk calculators need revising

Fauci's latest grilling in Congress: 9 hours, behind closed doors

knowledge

American woman, child freed after being kidnapped in Haiti last month

Drastic changes should bring profitability, startup health insurers say

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

Hospital chaplains balance Covid safety with patients’ spiritual needs

JPM pitch from hospitals? Revenue streams outside of patient care

Wegovy’s successful heart trial raises vital question about weight loss

focus

hotspot

focus

Wikipedia